(Alliance News) - Staff who work on patrol boats in the English Channel have voted for strike action in a dispute over allowances. The Public & Commercial Services union, PCS, said more than 100 of ...
(Alliance News) - Two vessels involved in a North Sea collision that triggered a huge explosion "appear to be relatively stable" and the environmental impact "mercifully small", a transport minister ...
(Alliance News) - Eric Trump, son of the US president, met with Scotland's First Minister John Sweeney Thursday, with talks focused on Donald Trump's golf ventures in the country.
(Alliance News) - Vladimir Putin has said he agrees in principle to a 30-day ceasefire with Ukraine as Downing Street warned that if the war continued sanctions would "cripple" the Russian economy.
(Alliance News) - Thames Water must wait to discover whether the approval of a plan to restructure the struggling utility will be overturned at the Court of Appeal.
(Alliance News) - Irish premier Micheal Martin has called for the EU to adopt a "strategic approach" around US tariffs, as he predicted difficulties for the Irish spirits industry. Martin was reacting ...
(Alliance News) - Ethernity Networks Ltd on Thursday said it expects to win an additional USD290,000 in a contract extension with a US-based aerospace system products provider.
The FTSE 100 index closed up just 1.59 points at 8,542.56. The FTSE 250 dropped 197.94 points, 1.0%, at 19,688.57, and the AIM All-Share fell 1.46 points, 0.2%, at 679.46. The Cboe UK 100 rose 0.1% at ...
(Alliance News) - Oxford BioDynamics PLC on Thursday announced an expanded strategic agreement with UK health insurance provider Bupa. The stock closed 9.7% higher at 0.52 pence per share on Thursday ...
(Alliance News) - LMS Capital PLC on Thursday said it will seek approval from shareholders for a managed realisation of its assets, following a review of its options. LMS Capital shares surged 16% to ...
(Alliance News) - Dar Global PLC on Thursday said it remains on track for its targets as it reported a fall in revenue and profit for 2024. The London-based luxury real estate developer which ...
ImmuPharma said the findings are from a new preclinical study designed by ImmuPharma Biotech's team, and will allow the company "to further expand its intellectual property portfolio, with additional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results